Liver X receptor unlinks intestinal regeneration and tumorigenesis
['Das, Srustidhar', 'Katajisto, Pekka', 'Villablanca, Eduardo J.']; Nature; 2024年11月20日
『Abstract』Uncontrolled regeneration leads to neoplastic transformation . The intestinal epithelium requires precise regulation during continuous homeostatic and damage-induced tissue renewal to prevent neoplastic transformation, suggesting that pathways unlinking tumour growth from regenerative processes must exist. Here, by mining RNA-sequencing datasets from two intestinal damage models and using pharmacological, transcriptomics and genetic tools, we identified liver X receptor (LXR) pathway activation as a tissue adaptation to damage that reciprocally regulates intestinal regeneration and tumorigenesis. Using single-cell RNA sequencing, intestinal organoids, and gain- and loss-of-function experiments, we demonstrate that LXR activation in intestinal epithelial cells induces amphiregulin ( Areg ), enhancing regenerative responses. This response is coordinated by the LXR-ligand-producing enzyme CYP27A1, which was upregulated in damaged intestinal crypt niches. Deletion of Cyp27a1 impaired intestinal regeneration, which was rescued by exogenous LXR agonists. Notably, in tumour models, Cyp27a1 deficiency led to increased tumour growth, whereas LXR activation elicited anti-tumour responses dependent on adaptive immunity. Consistently, human colorectal cancer specimens exhibited reduced levels of CYP27A1 , LXR target genes, and B and CD8 T cell gene signatures. We therefore identify an epithelial adaptation mechanism to damage, whereby LXR functions as a rheostat, promoting tissue repair while limiting tumorigenesis.
『摘要』
未受控制的再生会导致肿瘤转化。肠道上皮在持续稳态和损伤诱导的组织更新过程中需要精确的调控,以防止肿瘤转化,这表明一定存在将肿瘤生长与再生过程分离开来的途径。本研究通过挖掘两个肠道损伤模型的RNA测序数据集,并利用药理学、转录组学和遗传学工具,确定了肝X受体(LXR)通路激活是一种损伤后的组织适应反应,可相互调节肠道再生和肿瘤发生。通过单细胞RNA测序、肠道类器官以及功能增强和丧失实验,我们发现肠道上皮细胞中的LXR激活可诱导双调蛋白(Areg)的产生,从而增强再生反应。这一反应由LXR配体产生酶CYP27A1协调,该酶在受损的肠道隐窝微环境中上调。敲除Cyp27a1会损害肠道再生,而外源性LXR激动剂可以挽救这一现象。值得注意的是,在肿瘤模型中,Cyp27a1缺乏会导致肿瘤生长增加,而LXR激活则引发依赖于适应性免疫的抗肿瘤反应。同样,人类结直肠癌标本中的CYP27A1、LXR靶基因以及B细胞和CD8 T细胞基因特征均表达降低。因此,我们发现了一种上皮适应损伤的机制,其中LXR作为变阻器,在促进组织修复的同时限制肿瘤发生。
『总结』
研究表明,肝X受体(LXR)通路在肠道损伤后被激活,可协调组织再生并抑制肿瘤发生,为肠道上皮提供了一种适应损伤的机制。
【闲叙】